Zusammenfassung
Geringgradige Blutdruckerhöhungen werden relativ häufig und in allen Altersgruppen beobachtet. Eine einheitlich anerkannte Definition der sog. leichten Hypertonie fehlt, ebenso wie die Beantwortung der Frage, bis zu welchem Blutdruckwert eine Behandlung nicht erforderlich ist. Theoretisch müßte die Entscheidung zur Therapie durch die Höhe desjenigen Blutdruckwertes bestimmt werden, der das Risiko einer sog. Exzeßmorbidität und -mortalität zu einem zukünftigen Zeitpunkt in sich birgt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Alameda County Blood Pressure Study (1968) State of California, Department of Public Health, Berkeley
Ames RP, Hill P (1976) Increase in serum-lipids during treatment of hypertension with chlorthalidone. Lancet 1: 721–723
Davidson C, Thadani U, Singleton W, Taylor SH (1976) Comparison of beta-blocking drugs during chronic treatment. Brit Med J 3: 7–9
Day JL, Simpson N, Metcalfe J et al. (1979) Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Brit med J 1: 77–80
Dyer AR, Stamler J, Shekelle R, Schoenberger JA, Farinaro E (1977) Hypertension in the elderly. Med Clin North America 61: 513–529
Freis ED (1976) Salt, volume and the prevention of hypertension. Circulation 53: 589–595
Gluck Z, Weidmann P, Mordasini R et al. (1979) Einfluß einer Diuretikatherapie auf die Serumlipoproteine: Ein unerwünschter Effekt? Schweiz med Wschr 109: 104–108
Goldman AI, Steele BW, Schnaper HW et al. (1980) Serum lipoprotein levels during chlorthalidone therapy. J Amer med Ass 244: 1691–1695
Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H (1981) Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 94: 7–12
Hansson L, Werkö H (1977) Beta-adrenergic blockade in hypertension. Amer Heart J 93: 394–404
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. (1979) JAMA 242: 2562–71
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex, and age. (1979) JAMA 242: 2572–77
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure. (1982) JAMA 247: 633–38
Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in „mild“ hypertension. Results of the Hypertension Detection and Follow-up Program. (1982) New Engl J Med 307: 976–980
Kaplan NM (1981) Whom to treat: The dilemma of mild hypertension. Amer Heart J 101: 867–870
Joos C, Kewitz H, Reinhold-Kourniati D (1980) Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmaco117: 251–257
Julius S (1977) Borderline hypertension. An Overview. Med Clin North America 61: 495–510
Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: The Framingham study. Dis Chest 56: 43–52
Kokubu T, Itoh I, Kurita H, Coni T, Murata K, Yuba I (1982) Effect of prazosin on serum lipids. J Cardiovasc Pharmacol 4: 228–232
Leren P, Helgeland A, Holme J, Foss OP, Hjermann J, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4–6
Leren P, Foss OP, Helgeland A et al. (1981) Effects of pindolol and hydrochlorothiazide on blood lipids. The Oslo Study. Clin Trials J 18: 254–261
Levy RL, White PD, Stroud WD et al. (1945) Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129: 585–588
MacGregor GA, Markandu ND, Smith SJ, Banks RA, Sagnella GA (1982) Moderate potassium supplementation in essential hypertension. Lancet 2: 567–570
MacKenzie LF, Shepherd P (1937) The significance of past hypertension in applicants later presenting normal average blood pressures. Proc Ass Life Insur Med Dir Amer 24: 157–178
Mathisen HS, Loken H, Brox D et al. (1965) The prognosis in essential hypertension. Scand J Clin Lab Invest 17: 257–261
Metropolitan Life Insurance Company: Blood pressure: Insurance experience and its implications. (1961) Metropolitan Life Insurance Co., New York
Morgan T, Gillies A, Morgan G, Adam W, Wilson M, Carney S (1978) Hypertension treated by salt restriction. Lancet 1: 227–230
National High Blood Pressure Education Program. Report of Task Force 1 - Data Base. (1973) DHEW Publication No (NIH) 74–593
Overlack A, Stumpe KO (1978) Antihypertensiver Effekt einer fixen Beta-RezeptorenblockerDiuretikum-Kombination bei täglich einmaliger Applikation. Med Welt 29: 1517–1520
Priddle W, Liu S, Breithaupt D et al. (1968) Amelioration of high blood pressure in the elderly. J Amer Ger Soc 16: 887–892
Reisin E, Abei R, Modan M, Silverberg DS, Elia-hou H, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl J Med 298: 1–6
Shanks RG (1976) The properties of beta-adrenoceptor antagonists. Postgrad med J 52: 14–20
Stamler J, Lindberg HA, Berkson DM et al. (1958) Epidemiological analysis of hypertension and hypertensive disease in the labor force of a Chicago utility company. Proc Counc High Blood Press Res 7: 23–52
Stamler J, Berkson DM, Dyer A et al. (1975) Relationship of multiple variables to blood pressure. In: Paul O (ed) Epidemiology and Control of Hypertension. Symposia Specialists Miami, p 307
Stumpe KO, Kolloch RE (1977) Beta-blocking agents in the treatment of hypertension. Compreh Ther3: 55–65
Stumpe KO, Krück F (1982) Beta-adrenerge Rezeptorenblocker oder Diuretika zur Langzeittherapie der arteriellen Hypertension? DMW 107: 363–365
Stumpe KO, Kolloch RE, Vetter H et al. (1976) Acute and long-term studies of the mechanism of action of beta-blocking drugs in lowering blood pressure. Amer J Med 60: 853–865
Tanaka N, Sakaguchi S, Oshige K et al. (1976) Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 1071–1075
The Management Committee: The Australian therapeutic trial in mild hypertension. (1980) Lancet 1: 1261–1267
Thomas CB, Ross DC, Higgenbottom CQ (1964) Precursors of hypertension and coronary disease among healthy medical students. Discriminant function analysis II using parental history as the criterion Bull Johns Hopkins Hosp 115: 245
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II: Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. (1970)JAMA 213: 1143–1152
Waal-Manning HJ (1976) Hypertension: Which criterion. beta-blocker? Drugs 12: 412–441
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stumpe, K.O. (1984). Frühbehandlung der leichten Hypertonie. In: Rosenthal, J. (eds) Arterielle Hypertonie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00760-0_32
Download citation
DOI: https://doi.org/10.1007/978-3-662-00760-0_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-00761-7
Online ISBN: 978-3-662-00760-0
eBook Packages: Springer Book Archive